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Abstract
Background Since women pay more attention to their skin’s health, pharmaceutical companies invest heavily on skin care
product development. Further, the success of drug nano-carriers in passing through the skin justifies the need to conduct studies
at the nano-scale. β1-integrin down regulation has been proposed as a sign of skin aging.
Methods Six drug nano-carriers (50 and 75 nm) were prepared at three ethanol concentrations (0, 3,and 5%) and different
temperatures. Then, the impact of Nanocarriers on fibroblasts were investigated.
Results DLS showed that increasing ethanol concentration decreased the surface tension that caused a decrease in the particle size
in non-temperature formulations while increasing the temperature to 60 °C to lower Gibbs free energy increased the particle size.
Ethanol addition decreasedβ1-integrin over-expression, whereas larger nano-carriers induced an over-expression ofβ1-integrin, Bcl2/
Bax ratio, and an increase in live cell number.β1-integrin over-expression did not correlate with the rate of fibroblast proliferation and
NFκB expression. An increase in fibroblast mortality in relation to smaller nano-carriers was not only due to the increase in Bax ratio,
but was related to NFκB over-expression.
Conclusion The development of a regenerative pharmaceutical approach in skin repair was based on the effect of particle size and
ethanol concentration of the drug nano-carriers on the expression ofβ1-integrin in fibroblasts. A curcumin nanoformulation sized
77 nm and containing of 3% ethanol was more effective in increasing β1-integrin gene over-expression, anti-apoptosis of
fibroblast cells (Bcl2/Bax ratio), and in decreasing Bax and NFκB gene expression than that with a particle size of 50 nm.
Such a formulation may be considered a valuable candidate in anti-aging and wound-healing formulations.
Keywords Particle size . Nanocarriers . Surface tension, chemical stability, integrinβ1 . Skin aging .Wound healing.
Background
Nowadays, females have more concerns about skin
health than ever before. This point encourages the phar-
maceutical companies to invest on cosmetic industries.
To achieve this goal, it is necessary to have adequate
and accurate information about pharmaceutical dermal
products. Employment of drug nanocarriers seems to
be a proper strategy to effectively release and penetrate
drug combinations into the skin.
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The impact of nanotechnology in tissue engineering has
been led to desinging of more smart and bio-similar scaffolds.
There have diversity at the level of particle or fiber size and
also compartments [1, 2]. Whether particle size (50–80 nm)
and ethanol concentration (0%–5%; ethanol as a cosurfactant)
influence the expression of integrin-ß1 (a cell surface recep-
tor) and NFκB (an inflammatory factor) is an unanswered
question in dermal drug delivery. Dermal fibroblasts, as major
mesenchymal cells in the dermis, contribute to skin integrity
and structure. They are responsible for collagen synthesis,
while playing a critical role in skin aging and rejuvenation [3].
It is noteworthy that the Food and Drug Administration
(FDA) approved dermal fibroblasts for clinical applications
[4]. Dermal fibroblasts are involved in four main phases of
wound healing including hemostasis, inflammation, prolifera-
tion, and remodeling. Dermal fibroblasts trigger the inflamma-
tory phase through secretion of extracellular matrix (ECM)
biomolecules and then proliferate and differentiate into
myofibroblasts to induce wound contracture. In the final phase,
myofibroblasts undergo remodeling and apoptosis, while the
remaining dermal fibroblasts secrete type I collagen [4].
Due to some barriers such as the stratum corneum of the
skin, drug delivery to this site can be challenging, resulting in
decreased transdermal drug efficacy. Application of a pharma-
ceutical agent with proper physicochemical properties such as
unsaturated fatty acids and nanometer particle size induces
synergistic effects to increase drug penetration into the skin
[5]. Therefore, application of drug nanocarriers, which can
cross the stratum corneum and reach the dermis more effi-
ciently, is of interest to researchers [5].
The curcumin, as the bioactive compound of turmeric, is an
anti-inflammatory and antioxidant agent decreasing aging
through NFκB inhibition [6], lipofuscin reduction, and super-
oxide increment [7–9]. It seems that encapsulation into a
nanocarrier increases the efficacy of this extract and induces
its synergistic effects. Therefore, in the current study, curcumin
was encapsulated in a nanocarrier at two different particle sizes,
and ß1-integrin gene overexpression was compared.
First, cells respond to the environment via cell surface re-
ceptors such as ß1-integrin, while this interaction is disrupted
in the absence of such receptors. In this regard, Giangreco
et al., indicated that the level of ß1-integrin was significantly
higher in the skin of younger donors than the older ones.
There is a direct relationship between aging and integrin-ß1
downregulation, while ß1-integrin increment is significantly
associated with skin self-renewal [10]. However, other re-
searchers indicated the role of ß1-integrin in epidermal prolif-
eration, basement membrane formation, and hair follicle mor-
phogenesis in the skin of mice [11].
Liu et al., reported that ß1-integrin ablation in fibroblasts
results in delayed wound healing, reduces the production of
new ECM and type I collagen, decreases granulation tissue
formation, and inhibits fibroblast differentiation into
myofibroblasts [12]. Besides, Rozo et al., indicated the role
of ß1-integrin in the self-renewal of satellite cells through
restoring fibroblast growth factor (FGF-2) sensitivity [13].
To the best of authors` knowledge, no study investigated
the effect of particle size on ß1-integrin gene expression so far.
Therefore, evaluation of the effects of particle size on ß1-
integrin expression in fibroblasts can be useful to design phar-
maceutical agents to recover aging. The current study aimed at
investigating the impact of particle size and ethanol concen-
tration in curcumin nanocarriers on the overexpression of ß1-
integrins as cell surface receptors at the mRNA level.
NFκB is considered as a critical mediator of aging [14]
activated by oxidative stress and inflammatory agents. On the
other hand, it activates inflammatory cells involved in the pro-
cess of aging, as well. NFκB acts both as a prosurvival and cell
apoptotic factor in different cells [15]. Kriete et al., revealed
that NFκB and inflammatory factors are more activated in the
dermal fibroblasts of the elderly people than the younger ones
[16]. However, NFκB reduction in the skin of old mice led to
the improvement of age-related pathologies [14].
With regard to the importance of fibroblasts in wound
healing and skin repair and the role of ß1-integrin in aging,
Curcumin nanocarriers was prepared with six formulations,
two particle sizes (50 and 70 nm), and three ethanol concen-
trations (0%, 3%, and 5%) to evaluate particle size and ethanol
concentration of nanocarriers effects on ß1-integrin and NF B
gene expression, cell proliferation, and fibroblast viability.
Methods
Standard curve of curcumin
The maximumwavelength of curcumin was determined using
Spectroscopic analysis and then its standard curve was drawn.
In brief, a stock solution of curcumin containing 3.5 mg/ml
was prepared in ethanol and then, its standard serial dilution
was made. The absorbance of the sample was measured at the
maximum absorbance using UV-Vis spectrophotometer. The
assay was performed in triplicate and values provided are the
mean ± SD of three independent experiments.
Screening of oil
The solubility of curcumin in mineral, sesame and soybean
oils was determined by adding 1 mg of curcumin in 1 ml of
oils separately using a spectrophotometer. Then, they were
stirred (100 RPM) at 25 ± 1.0 °C for 48 h to achieve equilib-
rium. After 48 h, samples were centrifuged at 3000 RPM for
15 min and 100 μl of supernatant was taken and diluted with
solvent. The absorption was triplicate measured using a UV-
Vis spectrophotometer at 425 nm.
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Nano- carrier preparation
Curcumin nanocarriers were prepared using a low energy (oil
in water) emulsification method. Briefly, curcumin was added
to the soybean oil at the final concentration of 3%. Then to
obtain HLB 7, they were mixed with both non-ionic surfactants
of Tween and Span 80 at the final concentration of 10%. Tween
80 is a polyoxyethylene Sorbitan monooleate emulsifier
(hydrophil) while Span 80 is a sorbitan monooleate emulsifier
(lipophil). Ethanol as a co-surfactant was added at the final
concentrations of 0 and 3%, as well. After the homogeneously
stirring of the mixture for 5 min, water drop-wise was added at
low (25 °C) and high (60 °C) temperatures at 1200 RPM under
stirring condition. The samples with poor ethanol were named
3.10 (25 °C) and 3. 10 T (60 °C) while nanocarriers with 3%
ethanol were named 3.10.3 (25 °C) and 3.10.3T (60 °C).
Nano-carriers characterization
Hydrodynamic particle size
It was prepared six different types of curcumin nanocarriers and
they were denoted as 3.10, 3. 10 T, 3.10.3, 3.10.3T, 3.10.5 and
3.10.5T with the characteristics presented in Table 1. The hy-
drodynamic particle size of 3.10, 3. 10 T, 3.10.3, 3.10.3T, 3.10.5
and 3.10.5T were measured using a laser light scattering tech-
nique (Qudix scateroscope I (Korea)) with refractive index of
1.42 [17]. To prepare an inert medium for double layer of nano
carriers, they were disperesed in 10 mMmonovalent electrolyte
[18]. Light scattering was monitored by 300 s and the hydrody-
namic size of nanocarriers were measured in intensity mode.
Thermodynamic stability testing of curcumin nanocarriers
Thermodynamic stability of nanoemulsions was performed as
following. The first step was two freeze- thaw cycles between
−20 °C (24 h) and room temperature (25 °C). Then, it was
followed by the centrifugation at 5000 RPM for 30 min. The
final step was the six cycles of heating (40 °C) and cooling
(4 °C) by 48 h. The stable nanoemulsions do not show phase
separation or turbidity in each steps [19].
Chemical structure, stability testing of curcumin nanocarriers
by TLC
To investigate whether the formulations (surfactant and co-
surfactant) and temperatures degrade or damage to the chem-
ical structure of curcumin, thin layer chromatography was
performed. However, to compare the efficacy of two recom-
mended mobile phases, stationary phase separately kept in
mobile phases. Briefly, 10 μl of nanoemulsions were spotted
in 1 cm above the margin of silica gel F254 aluminum plate
(stationary phase). The plates were separately immersed in
two glass chambers containing hexane: ethyl acetate [7:3]
and chloroform: methanol [1:20] as a mobile phase.
Retention factor (Rf), is the distance migrated over the total
distance covered by the solvent. Then, bonds were visualized
and captured under UV irradiation equipped with a camera
[20]. The analysis was repeated 3 times.
pH measurement
The apparent pH of curcumin nanocarriers was measured
using a pH meter (Crison, Medidor PH BASIC 20, Spanish)
in triplicate at 25 °C.
Entrapment efficacy by ultrafiltration method
The unloaded curcumin was determined using separation by
ultrafiltration method. In brief, 500 μl of nano-formulations
was added to Amicon ultra-0.5 ml (molecular weight cutoff
10 kDa). Microtubes were centrifuged for 15 min at 14000 G.
The unloaded curcumin was collected and absorbance was read
using spectrophotometer at 425 nm. The concentration of
curcumin was determined using the formula derived from
curcumin standard curve. The assay was performed in triplicate
and values provided are the mean ± SD of three independent
experiments.










3.10 25 0 56.8 ± 0.1 5.2 ± 0.3 Stable Stable 99.9 ± 0.3
3. 10 T 60 0 78.3 ± 0.85 5 ± 0.2 Stable Stable 99.4 ± 0.6
3.10.3 25 3 56.8 ± 0.1 5.3 ± 0.3 Stable Stable 99.65 ± 0.7
3.10.3T 60 3 78.3 ± 0.85 5.2 ± 0.5 Stable Stable 98.3 ± 1.1
3.10.5 25 5 47.9 ± 1 5.2 ± 0.2 Stable Stable 99.35 ± 0.8
3.10.5T 60 5 70.7 ± 1 5.3 ± 0.1 Stable Stable 99.05 ± 0.41
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Cell metabolic activity using MTT assay
The cell metabolic activity evaluation of nanocarriers was
performed using MTT assay on L929 cells as a Mouse fibro-
blast cell line (Pasteur, Iran (C161)). 5× 103 cells/well at pas-
sage three were seeded triplicate in 96-well plate containing
DMEM as a cell culture medium supplemented with 10%
FBS (GIBCO), 1% Penicillin/Streptomycin (BIO-IDEA,
Iran) for 24 h. They were incubated at 37 °C in a 5% CO2
incubator. Then, the media was completely exchanged with
fresh medium containing drug nanocarriers at the final con-
centration of 312.5 ng/ml for 48 h at 37 °C in a 5% CO2 and
95% moisture incubator. Afterwards, the media were
completely removed and exchanged with the 100 μl of
3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium
(Sigma, USA) (0.5 mg/ml PBS) for 4 h. Then, dimethyl sulf-
oxide (DMSO; Sigma, USA) was added to dissolve hydrazine
crystal and the plate was read in a microplate reader (BioTek)
at 570 nm up to 20 min. The assay was performed in triplicate
and values provided are the normalized mean ± SD of three
independent experiments.
Cell viability assessment using PI flow cytometry
Propidium iodide as a marker of cell death, both late apoptotic
and necrotic cells was used for cell viability investigation.
After the cell seeding (3 × 104 and passage three) in a 24-
well plate, the cells were treated with 312.5 ng/ml of drug
nano-carriers at 37 °C in a 5% CO2 and 95% moisture for
48 h. To quantitatively investigate dead cells, flow-
cytometry was performed. Following the cell trypsinization,
they were centrifuged at 1200 RPM for 5 min and washed
with PBS. PI solution was added and incubated at dark room
temperature and flow cytometry was performed up to 30 min.
The assay was performed in triplicate and values provided are
the normalized mean ± SD of three independent experiments.
β1-integrin, NFκB, Bcl2/Bax ratio genes expression
To quantify the relative fold change gene expression at the
level of mRNA for β1-integrin, NFκB and Bcl2/Bax ratio,
L929 cells (1× 10 5 cell/well) in passage three were seeded
in a 6-well plate supplemented with RPMI, 10% FBS, 1%
penicillin/streptomycin overnight. Then, the media was
completely exchanged with fresh media containing
312.5 ng/ml of nano carriers by 48 h. RNAwas extracted from
treated cells using RNX- Plus kit (Sina clon, Iran) and treated
with DNAse I. cDNA (1 μg) was synthesized using a
TAKARA cDNA synthesis kit (Burlington, Japan). cDNA
was used for 45 cycles PCR in Rotor-gene Q real time ana-
lyzer (Corbett, Australia) using Eva Green master mix. Each
reaction was performed in duplicate and values provided are
the normalized mean ± SD of three independent experiments.
The relative fold change gene expression was quantified using
the DDCt method. The primer sequence of genes is listed in
Table 1.
Results
Oil screening of curcumin
Curcumin was dissolved in different oils and results showed
that there were no significant differences between the solubil-
ity of curcumin in soybean oil, sesame oil and mineral oil
(P > 0.05). However, sesame oil and soybean oil significantly
dissolved curcumin than mineral oil (p < 0.01 and 0.001, re-
spectively) (Fig. 1a).
To evaluate EE% and drug release, curve standard of
curcumin is necessary and results showed a linear relationship
between concentration and absorbtion at 425 nm (Fig. 1b).
Temperature exhibited significantly larger particle
size of nanocarriers
3.10, 3.10.3, 3.10.5, 3. 10 T, 3.10.3T, 3.10.5T nanocarriers
were prepared by the non-energetic method of stirring at 22
and 60 °C, respectively. Results showed that temperature in-
duced larger particle size of 78.3 ± 0.85 nm in 3. 10 T and
3.10.3T nanocarries as compared to the nanocarriers of 3.10
and 3.10.3 (56.8 ± 0.1 nm). Although 3.10.5 and 3.10.5Twere
compliant with the mentioned trend, the hydrodynamic parti-
cle size of them were less than other non-temperature and
temperature formulations (47.9 ± 1 and 70.7 ± 1, respective-
ly). It is worthy of value to be mentioned that the poly dispar-
ity index (PDI) of all nanoformulation was less than 0.3 and
temperature nano-formulations exhibited non- significant
higher PDI value (Table. 1).
Besides, pHmeasurement data disclosed that there were no
significant differences between all nano-formulations and they
were in the range of 5.2 ± 0.12 (p > 0.05).
Temperature and ethanol concentration do not
degrade the chemical structure of curcumin
in nanocarriers and also do not influence
on the thermodynamic stability of nanocarriers
TLC was performed to investigate whether temperature and
formulation ingredients affected the chemical structure of
curcumin. Results showed that not only formulation and tem-
perature did not degrade curcumin but also all nano-
formulations had equal Rf of 0.14 same as non-formulated
curcumin as a control (Fig. 2).
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Thermodynamic stability
Based on thermodynamic stability analysis (freeze-thaw, cen-
trifugation, heating-cooling), there were no sign of change in
the appearance and biphasic state of nano-formulations and all
nanoformulations showed thermodynamic stability (Table. 1).
EE% measurements
The percentage of EE non-significantly decreased in non-
temperature or smaller (~50 nm) nanoformulations with etha-
nol increment from 99.9 to 99.35%. Besides, larger nano-
formulation showed non-significantly less EE% than smaller
ones (Table 1).
Size and ethanol concentration of nanocarriers
influence cell surface receptor of β1-integrin
β1-integrin a cell surface receptor involved in fibrogenesis
and skin repair was investigated. Results showed that larger
nanoparticels induced significantly higher β1-integrin gene
overexpression compared to the smaller ones (p < 0.05).
Besides, increase of ethanol in the larger nanocarriers induced
higher β1-integrin gene overexpression. Although this trend
continued in smaller nanocarriers, nanocarriers with 3% etha-
nol concentration induced less β1-integrin gene expression
than others (p < 0.05) (Fig. 3a).
Bcl2/Bax ratio as an anti-apoptotic marker was
in good agreement with β1-integrin gene expression
We were going to curious about the influence of the particle
size and ethanol concentration on Bcl/Bax ratio as the index of
anti-apoptosis. Larger nano carriers except 3.10.5T lead to an
increase in the Bcl2/Bax ratio than smaller ones. Although
3. 10 T and 3.10.3T induced higher Bcl2/Bax ratio than the
control group (p < 0.05 and 0.001), 3.10.5T induced signifi-
cantly less Bcl2/Bax ratio than the control group (p < 0/05)
and there was no significant difference between cell viability
of 3.10.5 nanoformulation with the control group (p > 0.05),
(Fig. 3b).




DARU J Pharm Sci (2019) 27:159–168 163
Stimulation of integrin β1 by the size of nanocarriers
is opposite of NFκB expression while NFκB expression
is in agreement with cell proliferation assay
NFκB as a pro-inflammatory gene involved in ageing and skin
repair, was studied. Results showed that smaller nanocarriers
induced significantly higher level of NFκB gene expression
than larger ones (p < 0.05) while, addition of ethanol at both 3
and 5% concentrations decreased the level of NFκB as a pro-
inflammatory gene as compared to 0% concentration.
Interestingly, there were no significant differences between
NFκB gene expression of 3 and 5% ethanol concentrations
(p > 0.05), (Fig. 3c).
Cell proliferation assay by MTT assay was in opposite
of β1-integrin gene expression
Based on MTT assay data, curcumin nanocarriers induced
significantly higher cell proliferation than the control group
(p < 0.001) while the increase of particle size (temperature
formulation) and ethanol concentration from 0 to 3% induced
significantly less cell proliferation (P < 0.001). When size
falled into 49 and 70 nm, the trend changed and there was
no significant difference between cell metabolic activity of
3.10.5 and 3.10.5T (p > 0.05). In other word, both of them
induced significantly higher cell proliferation than 3
(p < 0.05) and 3 T (p < 0.01) respectively. Besides, there were
no significant differences between the cell proliferation of
3.10.5T with 3. 10 T and 3.10.3 (p > 0.05), and also between
3.10.5Tand 3.10.3 (p > 0.05). In another word, the increase of
ethanol in nano-formulations with the same size ((56.8 nm)
and (77.7–78.9 nm)) resulted in less cell proliferation
(p < 0.001) while in higher ethanol concentration (5%) with
smaller particle size (70.7 nm as compared to 77.7 and
78.9 nm), cell proliferation was singnificantly higher than
the lesser ethanol concentration (3%) (Fig. 4a).
Smaller nanocarriers induced higher percentage of PI
negative cells in agreement with MTT assay data
To confirmMTTassay data, PI flow-cytometry was performed.
It was disclosed that larger nanoformulation except 5% ethanol
concentration induced significantly less PI positive cells as
compared to the smaller nanocarriers. However, the increase
of ethanol concentration in small nanocarriers from 0 to 5% did
not change dead cells. The percentage of dead cells increased in
groups treated with larger nanocarriers around 70 nm at the
concentration of 0 to 3%, while it significantly decreased at
5% ethanol concentration (P < 0.5), (Fig. 4b).
Discussion
There are diverse strategies to manipulate wrinkle, skin scars
and burns using nanofiberous scaffolds [21] and other bioma-
terials [22].Meanwhile, there are different reports on the effect
Fig. 2 a Oil screening of curcumin with the mineral oil, sesame oil and soybean oil. b Curve standard of curcumin solved in ethanol (3mg/ml)
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of particle size of nanoparticles [23–25] and nanofiber diam-
eter [26] on bone and nerve regeneration, but there are no
reports on the impact of particle size of drug nanocarriers
and ethanol concentration on skin repair. Therefore, In the
current study, curcumin nanocarriers were prepared with two
particle sizes (about 50 and 70 nm), and the effects of temper-
ature and ethanol concentration on particle size, pH, and
chemical and thermodynamic stability were studied. Based
on the current study findings, temperature increased the parti-
cle size of nanocarriers, while there was no significant associ-
ation between EE% (data not shown) and pH of nanocarriers.
Moreover, the released profile of nanocarriers was influenced
by ethanol concentration, which increased from 0% to 5%
(data not shown). Changes in ethanol concentration (0%–
5%) and temperature (60 °C) did not influence the chemical
structure or thermodynamic stability of nanocarriers, while
Fig. 3 a Integrin β1 gene
expression in fibroblasts treated
with curcumin nanocarriers.
Larger nanocarriers induced
significantly higher Integrin β1
gene expression than smaller
compartments. b NFκB gene
expression in fibroblasts treated
with nanocarriers. qRT-PCR re-
sults showed that larger
nanocarriers decreased signifi-
cantly less level of NFκB gene
expression. c Bcl2/ Bax ratio in
fibroblasts treated with
nanocarriers. qRT-PCR results
showed that larger nanocarriers
increased significantly Bcl2/ Bax
ratio as an anti-apoptotic marker
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hydrodynamic particle size decreased as the ethanol concen-
tration increased from 3% to 5%.
Chin et al. [27] demonstrated that the particle size of starch
nanoparticles, prepared by themicroemulsionmethod, decreased
relative to cyclohexane/ethanol concentration, which was in
good agreement with the current study findings. It can be said
that an increase in the level of ethanol as a cosurfactant decreases
the interfacial tension of oil and water, resulting in the reduction
of particle size. However, an increase in ethanol concentration
from 0% to 3% was not sufficient to cover the entire surface of
droplet and did not change the particle size; on the other hand,
when ethanol concentration increased to 5%, it could cover the
entire surface and produced smaller nanoparticles.
Nonetheless, Chin et al. [27] showed that increased ethanol
concentration led to an increase in surface fluidity, which in
turn improved the intermicellar exchange kinetics; this phe-
nomenon contributes to the homogenous distribution of nano-
particles. Ethanol decreases the particle size in nanoemulsion
systems, and its addition to substances such as gasoline and
ethylene decreases particle size through reducing soot precur-
sor nucleation and growth [28].
Another finding of the current study was the impact of
temperature on particle size. Qu et al. reported that an increase
in temperature decreases surface tension and increases metal-
lic particle size [29]. Although these findings were in good
agreement with those of the current study, since the size of
nanocarriers increased with temperature, the data were not
convincing and may be attributed to reducing Gibbs free en-
ergy. In fact, increased temperature improves Gibbs free ener-
gy, while the system tends to decrease this level in order to
improve thermodynamic stability; therefore, nucleation,
growth, and aging processes are triggered.
In the current study, the increase in ethanol concentration
from 3% to 5% and temperature from 22 °C to 60 °C respec-
tively decreased and increased the particle size in drug
nanocarriers through reducing surface tension and improving
Gibbs free energy. Based on these findings, the increase in
ethanol concentration from 3% to 5%decreased surface tension
and consequently the particle size from 56.8 ± 0.1 to 47.9 ± 1 in
a non-temperature setting. On the other hand, the increase in
temperature (60 °C) decreased Gibbs free energy by improving
nanocarrier nucleation and growth. At 5% ethanol concentra-
tion, the low surface tension overcame the increase in the Gibbs
free energy of nanocarriers, and nanocarrier particle size was
less than that of reported at 3% ethanol concentration.
Based on the current study findings, particle size influences
ß1-integrin gene expression, and larger nanocarriers induce the
overexpression of ß1-integrin in fibroblast cells. As mentioned
earlier, ß1-integrin overexpression in fibroblasts leads to
wound healing and increases the production of new ECM and
type I collagen [12]. Moreover, soybean oil in nanoemulsions
contains unsaturated fatty acids, which help change the spacing
Fig. 4 a Cell proliferation of
fibroblasts treated with
nanocarriers by MTT assay.
Smaller nanocarriers induced
significantly higher cell
proliferation than larger ones. b
Cell viability of fibroblasts treated
with nanocarriers by PI flow-
cytometery method. Smaller
nanocarriers induced significantly
higher cell viability than larger
ones with an increase in PI nega-
tive cells
166 DARU J Pharm Sci (2019) 27:159–168
of lipid bilayer in the stratum corneum and increase dermal
delivery [5]. These findings may be valuable to pharmaceutical
companies not to underscore the importance of nanocarrier
particle size in the design of aging and wound healing products.
While larger nanocarriers (about 70–77 nm) induced ß1-
integrin gene overexpression, smaller nanocarriers induced
higher cell proliferation and cell viability, compared with larger
nanocarriers. Brockbank et al. showed that ß1-integrin is not
essential to proliferation of vulvar squamous cell carcinoma
cells, while it is necessary for cell adhesion [30]. This finding
was in agreement with the current study findings, which indi-
cated that ß1-integrin overexpression was not associated with
fibroblast cell proliferation. However, some studies reported
the concomitant occurrence of ß1-integrin overexpression and
proliferation of epidermal [11] and satellite cells [13].
Another important finding of the current study was the
Bcl2/Bax ratio as a marker of anti-apoptosis. Although the
results were consistent and larger nanocarriers induced less
fibroblast cell apoptosis, they were also associated with ß1-
integrin overexpression. It seems that 77-nm nanocarriers in-
duced cell viability less efficiently than 50-nm nanocarriers in
agreement with smaller nanocarriers in which they could in-
duce higher cell metabolic assay or cell proliferation.
The increase of fibroblast apoptosis marker in smaller
nanocarriers was due to the increased Bax ratio and the in-
creased NFκB overexpression. Therefore, ß1-integrin overex-
pression leads to the downregulation of Bax as an apoptotic
gene and NFκB as an inflammatory one. NFκB was involved
in aging [14] and death of some cells; also, NFκB overexpres-
sion is higher in older skins than younger ones [15, 16], these
findings were in good agreement with the current study data.
However, others indicated that NFκB increment was in good
agreement with cell proliferation of mammary epithelial cells
and other cell types as observed in the current study.
Conclusion
In conclusion, curcumin nanocarriers of about 77 nm (without
ethanol as a cosurfactant) induced more ß1-integrin overex-
pression, while addition of 3% ethanol decreased cell apopto-
sis, Bax, and NFκB genes. Based on the current study find-
ings, a curcumin nanoformulation, containing 3% ethanol in
the range of 77 nm, was more effective than a nanoformula-
tion with a particle size of about 50 nm to decrease cell death
(PI-positive and Bax/Bcl2 ratio) and expression of apoptotic
(Bax) and proinflammatory (NFκB) genes; therefore, these
formulations may be valuable in ageing and wound healing.
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